Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Cost of Revenue: 2009-2025

Historic Cost of Revenue for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $429.4 million.

  • BIO-TECHNE's Cost of Revenue fell 7.51% to $98.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $421.4 million, marking a year-over-year increase of 4.29%. This contributed to the annual value of $429.4 million for FY2025, which is 10.28% up from last year.
  • Latest data reveals that BIO-TECHNE reported Cost of Revenue of $429.4 million as of FY2025, which was up 10.28% from $389.3 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Cost of Revenue ranged from a high of $429.4 million in FY2025 and a low of $298.2 million during FY2021.
  • Over the past 3 years, BIO-TECHNE's median Cost of Revenue value was $389.3 million (recorded in 2024), while the average stood at $395.2 million.
  • Data for BIO-TECHNE's Cost of Revenue shows a peak YoY rose of 17.08% (in 2022) over the last 5 years.
  • BIO-TECHNE's Cost of Revenue (Yearly) stood at $298.2 million in 2021, then climbed by 17.08% to $349.1 million in 2022, then rose by 5.09% to $366.9 million in 2023, then increased by 6.12% to $389.3 million in 2024, then climbed by 10.28% to $429.4 million in 2025.